Wednesday, July 8, 2026

pharma · Cancer Anorexia · ARTL

ARTELO BIOSCIENCES

ARTELO BIOSCIENCES clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

La Jolla, USA HQ
2017 Founded
16 Employees
Public company Type
ARTL · NYSE Ticker
Company details
Status
Public
HQ
La Jolla, USA
Founded
2017
Employees
16
Programs
1
Drugs
1
Patents
2
Intelligence · Clinical Programs

ARTELO BIOSCIENCES projects

1 ClinicalTrials.gov programs sponsored by ARTELO BIOSCIENCES.

ARTELO BIOSCIENCES has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. ART27.13-100

    ARTELO BIOSCIENCES, INC.

    Cancer Anorexia

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does ARTELO BIOSCIENCES have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.